Literature DB >> 9790660

Use of cervical and breast cancer screening among women with and without functional limitations--United States, 1994-1995.

.   

Abstract

The national health objectives for 2000 include increasing to at least 85% the proportion of all women aged > or =18 years who have received a Papanicolaou test within the preceding 3 years and increasing to at least 80% the proportion of women aged > or =40 years who have ever had a mammogram. However, national data on breast and cervical cancer screening specifically for women with disabilities is limited. During 1994-1995, CDC, 12 other federal agencies, and one foundation sponsored a disability survey as a special supplement to the National Health Interview Survey (NHIS). In 1994, questions on breast and cervical cancer screening were included in the NHIS Health Promotion/Disease Prevention Year 2000 Objectives Supplement. This report provides the findings of an analysis of these linked data, which indicate that women with functional limitations (FLs) were less likely than women without FLs to have had a Pap test within the previous 3 years, and women aged > or =65 years with three or more FLs were less likely to have ever had a mammogram compared with similarly aged women with no limitations.

Entities:  

Mesh:

Year:  1998        PMID: 9790660

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  13 in total

1.  Factors important in promoting cervical cancer screening among Canadian women: findings from the 1996-97 National Population Health Survey (NPHS).

Authors:  C J Maxwell; C M Bancej; J Snider; S A Vik
Journal:  Can J Public Health       Date:  2001 Mar-Apr

Review 2.  Health disparities between women with and without disabilities: a review of the research.

Authors:  Jennifer P Wisdom; Marjorie G McGee; Willi Horner-Johnson; Yvonne L Michael; Elizabeth Adams; Michelle Berlin
Journal:  Soc Work Public Health       Date:  2010-05

3.  Breast cancer screening barriers and disability.

Authors:  Ana Todd; Alexa Stuifbergen
Journal:  Rehabil Nurs       Date:  2012 Mar-Apr       Impact factor: 1.625

4.  Does a standard measure of self-reported physical disability correlate with clinician perception of impairment related to cancer screening?

Authors:  David I Buckley; Melinda M Davis; Elena M Andresen
Journal:  Cancer       Date:  2011-08-23       Impact factor: 6.860

5.  Disability and preventive cancer screening: results from the 2001 California Health Interview Survey.

Authors:  Anthony Ramirez; Gail C Farmer; David Grant; Theodora Papachristou
Journal:  Am J Public Health       Date:  2005-09-29       Impact factor: 9.308

6.  Repeat mammography screening among unmarried women with and without a disability.

Authors:  Melissa A Clark; Michelle L Rogers; Xiaozhong Wen; Victoria Wilcox; Kate McCarthy-Barnett; Jeanne Panarace; Carol Manning; Susan Allen; William Rakowski
Journal:  Womens Health Issues       Date:  2009-09-23

7.  Breast and cervical cancer screening practices among disabled women aged 40-75: does quality of the experience matter?

Authors:  Sze Y Liu; Melissa A Clark
Journal:  J Womens Health (Larchmt)       Date:  2008-10       Impact factor: 2.681

Review 8.  Pap, mammography, and clinical breast examination screening among women with disabilities: a systematic review.

Authors:  Elena M Andresen; Jana J Peterson-Besse; Gloria L Krahn; Emily S Walsh; Willi Horner-Johnson; Lisa I Iezzoni
Journal:  Womens Health Issues       Date:  2013 Jul-Aug

9.  Pregnancy among US women: differences by presence, type, and complexity of disability.

Authors:  Willi Horner-Johnson; Blair G Darney; Sheetal Kulkarni-Rajasekhara; Brian Quigley; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2015-11-04       Impact factor: 8.661

10.  Geographic variation and effect of area-level poverty rate on colorectal cancer screening.

Authors:  Min Lian; Mario Schootman; Shumei Yun
Journal:  BMC Public Health       Date:  2008-10-16       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.